Japanese society of dialysis therapy treatment guidelines for secondary hyperparathyroidism

Therapeutic Apheresis and Dialysis

Volumn 11, Issue SUPPL. 1, 2007, Pages

  Kazama, Junichiro James ^a,b  

^a Niigata University Medical and Dental Hospital ^*  (Japan)

^b NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

Author keywords

Life prognosis; Parathyroid function; Parathyroid intervention; Secondary hyperparathyroidism; Vitamin D therapy

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANGINA PECTORIS; BONE METABOLISM; BONE PAIN; CALCANEUS; CALCIUM BLOOD LEVEL; CONFERENCE PAPER; DIALYSIS; DRUG DOSE REDUCTION; HEART FAILURE; HORMONE BLOOD LEVEL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; JAPAN; PARATHYROID FUNCTION; PARATHYROID GLAND; PHOSPHATE BLOOD LEVEL; PRACTICE GUIDELINE; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; SOCIETY; SURVIVAL; THORAX RADIOGRAPHY;

AGED; CALCIUM; HUMANS; HYPERPARATHYROIDISM, SECONDARY; JAPAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PARATHYROID HORMONE; PHOSPHORUS; PRACTICE GUIDELINES AS TOPIC; RENAL DIALYSIS; SOCIETIES, MEDICAL; SURVIVAL RATE; TREATMENT OUTCOME; VITAMIN D;

EID: 35748970717     PISSN: 17449979     EISSN: 17449987     Source Type: Journal    
DOI: 10.1111/j.1744-9987.2007.00516.x     Document Type: Conference Paper

References (8)

1. Moe S, Drueke T, Cunningham J et al. Kidney Disease: Improving Global Outcomes (KDIGO). Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int 2006 69: 1945 53.
2. Wood C, Gonzalez EA, Martin KJ. Challenges in the therapy of secondary hyperparathyroidism. Ther Apher Dial 2005 9: 4 8.
3. K/DOQI clinical practice guidelines for bone mineral metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003 42 (Suppl. 3 S7 201.
4. Nakai S, Akiba T, Kazama JJ et al. Effects of serum levels of calcium, phosphorous, and intact parathyroid hormone levels on survival in chronic hemodialysis patients in Japan. Ther Apher Dial (in press).
5. Fukagawa M, Kazama JJ, Shigematsu T. Skeletal resistance to PTH as a basic abnormality underlying uremic bone diseases. Am J Kidney Dis 2001 38: S152 5.
6. Quarles LD, Lobaugh B, Murphy G. Intact parathyroid hormone overestimates the presence and severity of parathyroid-mediated osseous abnormalities in uremia. J Clin Endocrinol Metab 1992 75: 145 50.
7. Block GA, Klassen PS, Lazarus JM et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004 15: 2208 18.
8. Fukagawa M, Nakanishi S. Role of parathyroid intervention in the management of secondary hyperparathyroidism. Nephrol Dial Transplant 2003 18: iii23 6.